Novo Nordisk A/S (NVO)
Novo Nordisk A/S Accounts Receivables
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Receivables | $832.2M | $971.7M | $1,147.6M | $1,426.8M | $1,632.4M | $1,753.5M | $1,957.5M | $2,029.9M | $2,212.7M | $2,009.1M | $2,117.9M | $2,253.1M | $3,421.5M | $3,789.4M | $4,130.2M | $4,364.1M | $5,271.7M | $7,152.8M | $8,252.0M | $11.1B |
Novo Nordisk A/S (NVO) Accounts Receivables comparison analysis
NVO key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Novo Nordisk A/S's Accounts Receivables?
As of today, Novo Nordisk A/S's last 12-month Accounts Receivables is $10.4B, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Novo Nordisk A/S's Accounts Receivables growth rate?
Over the last year, Novo Nordisk A/S's Accounts Receivables growth was 18.4%. The average annual Accounts Receivables growth rates for Novo Nordisk A/S have been 32.9% over the past three years, 21.8% over the past five years.
3) Is Novo Nordisk A/S's Accounts Receivables growth rate Good?
Over the last year, Novo Nordisk A/S's Accounts Receivables growth was 18.4%, which is higher than industry growth of (0.3%). It indicates that Novo Nordisk A/S's Accounts Receivables growth is Bad.